|
|
| (11 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| [[Image:2a01.gif|left|200px]]
| | <span style='background-color: yellow;'>For additional information see '''2009, December:''' at [[Retractions and Fraud]].</span></br>REMOVED: The PDB entry 2a01 was removed. |
| | |
| {{Structure
| |
| |PDB= 2a01 |SIZE=350|CAPTION= <scene name='initialview01'>2a01</scene>, resolution 2.40Å
| |
| |SITE=
| |
| |LIGAND= <scene name='pdbligand=AC9:TRISACETYLACETONATOCHROMIUM(III)'>AC9</scene>
| |
| |ACTIVITY=
| |
| |GENE=
| |
| }}
| |
| | |
| '''Crystal Structure of Lipid-free Human Apolipoprotein A-I''' | |
| | |
| | |
| ==Overview==
| |
| Despite three decades of extensive studies on human apolipoprotein A-I (apoA-I), the major protein component in high-density lipoproteins, the molecular basis for its antiatherogenic function is elusive, in part because of lack of a structure of the full-length protein. We describe here the crystal structure of lipid-free apoA-I at 2.4 A. The structure shows that apoA-I is comprised of an N-terminal four-helix bundle and two C-terminal helices. The N-terminal domain plays a prominent role in maintaining its lipid-free conformation, indicating that mutants with truncations in this region form inadequate models for explaining functional properties of apoA-I. A model for transformation of the lipid-free conformation to the high-density lipoprotein-bound form follows from an analysis of solvent-accessible hydrophobic patches on the surface of the structure and their proximity to the hydrophobic core of the four-helix bundle. The crystal structure of human apoA-I displays a hitherto-unobserved array of positively and negatively charged areas on the surface. Positioning of the charged surface patches relative to hydrophobic regions near the C terminus of the protein offers insights into its interaction with cell-surface components of the reverse cholesterol transport pathway and antiatherogenic properties of this protein. This structure provides a much-needed structural template for exploration of molecular mechanisms by which human apoA-I ameliorates atherosclerosis and inflammatory diseases.
| |
| | |
| ==Disease==
| |
| Known diseases associated with this structure: Amyloidosis, 3 or more types OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=107680 107680]], ApoA-I and apoC-III deficiency, combined OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=107680 107680]], Corneal clouding, autosomal recessive OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=107680 107680]], Hypertriglyceridemia, one form OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=107680 107680]], Hypoalphalipoproteinemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=107680 107680]]
| |
| | |
| ==About this Structure==
| |
| 2A01 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2A01 OCA].
| |
| | |
| ==Reference==
| |
| Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases., Ajees AA, Anantharamaiah GM, Mishra VK, Hussain MM, Murthy HM, Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2126-31. Epub 2006 Feb 1. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16452169 16452169]
| |
| [[Category: Homo sapiens]]
| |
| [[Category: Single protein]]
| |
| [[Category: Ajees, A A.]]
| |
| [[Category: Anantharamaiah, G M.]]
| |
| [[Category: Hussain, M M.]]
| |
| [[Category: Mishra, V K.]]
| |
| [[Category: Murthy, K H.M.]]
| |
| [[Category: AC9]]
| |
| [[Category: four-helix bundle]]
| |
| | |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 15:43:48 2008''
| |
For additional information see 2009, December: at Retractions and Fraud.
REMOVED: The PDB entry 2a01 was removed.
